AHA comments on the bipartisan leadership in introducing the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA Comments on the Department of Homeland Security’s (DHS) proposed fee for H-1B petitions.
AHA comments on the Centers for Medicare & Medicaid Services's proposed rule regarding the indirect hold harmless threshold of healthcare-related taxes.
AHA comments on the CMS physician fee schedule proposed rule for calendar year 2027.
AHA comments on NAIC Health Care Affordability Issue Briefs.
AHA comments on the Center for Medicare & Medicaid Service’s calendar year 2027 HH prospective payment system (PPS) proposed rule.
AHA comments on the CMS’ hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year CY 2027.
AHA comments on two aspects of the Centers for Medicare & Medicaid Services’ (CMS) 2027 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Rule.
AHA provides feedback on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) discussion draft.
The AHA's principal recommendation is that CMS use its authority to require drug manufacturers to make the Maximum Fair Price (MFP) available through a prospective, point-of-sale mechanism and eliminate any option that would permit manufacturers to satisfy their obligations through retrospective rebates or post-sale reconciliations.